Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × ferric derisomaltose × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Iron-Deficiency 1 Anemia 1

Interventions

pembrolizumab 503 Specimen Handling 397 Carboplatin 379 Magnetic Resonance Spectroscopy 364 Cisplatin 353 Cyclophosphamide 339 Radiotherapy 278 Gemcitabine 266 Bevacizumab 261 Paclitaxel 252 Biopsy 219 Drug Therapy 208 venetoclax 200 fludarabine 199 Capecitabine 193 Nivolumab 190 Oxaliplatin 189 Docetaxel 181 Injections 179 Fluorouracil 167 Dexamethasone 158 Radiosurgery 146 Rituximab 138 Pemetrexed 137 durvalumab 126 Standard of Care 124 atezolizumab 120 tislelizumab 117 Azacitidine 113 toripalimab 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05407987 2025-04-25

FORGE II

AHS Cancer Control Alberta

Phase 3 Recruiting

Classical hematology

Anemia, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡